Saturday Afternoon Session Orange Oral Presentation

Saturday, April 26, 2014: 4:30 PM-5:00 PM

4:30 PM

Facelift Combined with Simultaneous Fractional Laser Resurfacing: Outcomes and Complications
Steve Struck, private practice, Atherton, CA and Eric Wright, MD, Stanford University, Palo Alto, CA

4:38 PM

ATX-101, a Submental Contouring Injectable Drug for the Reduction of Submental Fat: A Pooled Analysis of Two Pivotal Phase 3 (REFINE-1 And REFINE-2) Multicenter, Double-Blind, Randomized, Placebo-Controlled Trials
Steven H. Dayan, MD¹, Derek H. Jones, MD², Jean Carruthers, MD, FRCS(c)³, Shannon Humphrey, MD³, Fredric S. Brandt, MD⁴, Patricia Walker, MD, PhD⁵, Daniel Lee, MS⁶, Paul F. Lizzul, MD, PhD⁶ and Frederick C. Beddingfield III, MD, PhD⁶, (1)Private Practice, Chicago, IL, (2)Private Practice, Los Angeles, CA, (3)University of British Columbia, Vancouver, BC, Canada, (4)Private Practice, Coral Gables, FL, (5)Private Practice, Carpinteria, CA, (6)Kythera Biopharmaceuticals, Inc., Calabasas, CA

4:46 PM

Duration of Effect By Injection Volume and Facial Sub-Region for a Volumizing Hyaluronic Acid Filler in Treating Mid-Face Volume Deficit
Jeffrey M. Kenkel, MD, FACS¹, Dee Anna Glaser, MD², Deepali Paradkar, PhD³ and Diane K. Murphy, MBA³, (1)University of Texas Southwestern, Dallas, TX, (2)Saint Louis University, St. Louis, MO, (3)Allergan, Inc., Santa Barbara, CA